Inotuzumab ozogamicin (CMC-544) compared to chemotherapy in patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL): A retrospective comparison

被引:0
作者
Faderl, Stefan
Jain, Nitin
O'Brien, Susan Mary
Thomas, Deborah A.
Ravandi, Farhad
Jabbour, Elias
Pierce, Sherry
Kantarjian, Hagop M.
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7095
引用
收藏
页数:1
相关论文
empty
未找到相关数据